Erin Wang, Xiangrong Kong, Meraf Wolle, Nicolas Gasquet, Joseph Ssekasanvu, Silvio P Mariotti, Rupert Bourne, Hugh Taylor, Serge Resnikoff, Sheila West
TOPIC: We provide global estimates of the prevalence of corneal blindness and vision impairment in adults 40 years and older and examine the burden by age, gender, and geographic region from 1984-2020. CLINICAL RELEVANCE: Corneal opacities (CO) are among the top five causes of blindness worldwide, yet the global prevalence, regional differences, and risk factors are unclear. METHODS: Abstracted data from the published literature and surveys were obtained from the Global Burden of Disease Vision Loss Expert Group...
March 22, 2023: Ophthalmology
Mette Bagger, Charlotte Espensen, Kristina Rasmussen, Mehmet Dogrusöz, Martine J Jager, Ane Appelt, Jens F Kiilgaard
OBJECTIVE: Increased disease-specific mortality has been observed among patients with local recurrence (LR) from uveal melanoma, but the underlying mechanism is unknown. The purpose of this study was to determine if copy number alterations of chromosomes 3 and 8q, at the time of diagnosis, increase the incidence of LR and if disease-specific mortality among patients with LR depends on the chromosome status of the primary tumor. STUDY DESIGN: Retrospective cohort study SUBJECTS: The study included 239 consecutive patients with primary uveal melanoma (choroidal or ciliary body) treated with Ru-106 brachytherapy, from January 2009 to December 2019 at a single national referral center...
March 17, 2023: Ophthalmology
Thomas A Weppelmann, Curtis E Margo, Edgar M Espana
No abstract text is available yet for this article.
March 14, 2023: Ophthalmology
Khanh Bui, Carol L Shields, Tatyana Milman
No abstract text is available yet for this article.
March 14, 2023: Ophthalmology
Maurizio Tomaiuolo, Fasika A Woreta, Alexander Li, Yoshihiro Yonekawa, Qiang Zhang, James E Sharpe, Sidra Zafar, Zeba A Syed, Sathyadeepak Ramesh, Alice C Lorch, Nathan E Hall, Ankoor S Shah, Grant A Justin, Leslie Hyman
PURPOSE: To estimate incidence and evaluate demographic risk factors and visual acuity (VA) outcomes of open globe injuries requiring surgical repair in the IRIS® Registry (Intelligent Research in Sight). DESIGN: Retrospective cohort study. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: Patients with open globe injury repairs (OGR) were identified by Current Procedural Terminology codes (65275, 65280, 65285, 65286, 65235, 65260, 65265) from 2014 to 2018 in the IRIS Registry...
March 14, 2023: Ophthalmology
Kevin R Card, Matthew R Barke, Jerry A Shields
No abstract text is available yet for this article.
March 13, 2023: Ophthalmology
Brooke Sherry, Samuel Lee, Maria De Los Angeles Ramos Cadena, Gregory Laynor, Sheel R Patel, Maxine dellaBadia Simon, Eric G Romanowski, Sarah E Hochman, Joel S Schuman, Christina Prescott, Cassandra L Thiel
TOPIC: Understanding approaches to sustainability in cataract surgery and their risks and benefits CLINICAL RELEVANCE: In the United States, healthcare is responsible for approximately 8.5% of greenhouse gas (GHG), and cataract surgery is one of the most commonly performed surgical procedures. Ophthalmologists can contribute to reducing GHG emissions, which lead to a steadily increasing list of health concerns ranging from trauma to food instability. METHODS: We conducted a literature review to identify the benefits and risks of sustainability interventions...
March 6, 2023: Ophthalmology
Carl Regillo, Brian Berger, Logan Brooks, W Lloyd Clark, Robert Mittra, Charles C Wykoff, Natalia F Callaway, Stephanie DeGraaf, Han Ting Ding, Anne E Fung, Shamika Gune, Sophie Le Pogam, Robert Smith, Jeffrey R Willis, Giulio Barteselli
PURPOSE: To report 2-year results from the Archway clinical trial of the Port Delivery System with ranibizumab (PDS) for treatment of neovascular age-related macular degeneration (nAMD). DESIGN: Phase 3, randomized, multicenter, open-label, active-comparator trial. PARTICIPANTS: Patients with previously treated nAMD diagnosed within 9 months of screening and responsive to anti-vascular endothelial growth factor therapy. METHODS: Patients were randomized 3:2 to PDS with ranibizumab 100 mg/ml with fixed refill-exchanges every 24 weeks (PDS Q24W) or intravitreal ranibizumab 0...
March 2, 2023: Ophthalmology
Yihong Huang, Lijuan Huang, Yingying Gao
No abstract text is available yet for this article.
March 1, 2023: Ophthalmology
Rahul N Khurana, Charles Li, Flora Lum
OBJECTIVE: To determine the incidence of loss to follow up (LTFU) and nonpersistence in patients with neovascular age related macular degeneration (AMD) treated with anti-vascular endothelial growth factor (VEGF) injections in the United States. DESIGN: Retrospective cohort study using IRIS (Intelligent Research in Sight) Registry data. SUBJECTS: 156,327 treatment-naïve neovascular AMD patients who were subsequently treated with anti-VEGF therapy from 2013 to 2015 and followed through 2019...
February 27, 2023: Ophthalmology
Sonam Yangzes, Kanupriya Raghav, Chintan Malhotra
No abstract text is available yet for this article.
February 25, 2023: Ophthalmology
Mark A Bullimore, Noel A Brennan
No abstract text is available yet for this article.
February 24, 2023: Ophthalmology
Guangwei Yu, Xinyao Han, Donglin Wang
No abstract text is available yet for this article.
February 23, 2023: Ophthalmology
Muhammad Z Chauhan, Abdelrahman M Elhusseiny, Brita S Rook, Esaa S Samarah, Sami H Uwaydat, Ahmed B Sallam, Paul H Phillips
Adolescent Hispanic children were more likely to report vision impairment, while adolescent non-Hispanic Black children were more likely to report unmet vision needs compared to non-Hispanic White children. These disparities persisted across socioeconomic levels and were exacerbated by the COVID-19 pandemic.
February 22, 2023: Ophthalmology
Katarina Stingl, Krunoslav Stingl, Hillary Schwartz, Mark W Reid, Melanie Kempf, Spyridon Dimopoulos, Friederike Kortuem, Mark S Borchert, Thomas C Lee, Aaron Nagiel
PURPOSE: To analyze demographic and ophthalmologic data in patients with and without chorioretinal atrophy after voretigene neparvovec-rzyl (VN) in order to identify possible causes for this phenomenon. DESIGN: Retrospective cohort study with longitudinal follow-up. SUBJECTS: 71 eyes of 38 patients aged 2 to 44 years with RPE65-mediated retinal dystrophy treated with VN across two large gene therapy centers in the USA and Germany. METHODS: VN-treated patients who developed atrophy were compared to those who did not...
February 21, 2023: Ophthalmology
Do Young Park, Mina Kim, Yoonjong Bae, Hyemin Jang, Dong Hui Lim
PURPOSE: To investigate the risk of dementia in participants with newly diagnosed glaucoma. DESIGN: A nationwide cohort study using authorized data provided by the Korean National Health Insurance Service (NHIS). PARTICIPANTS: A total of 788,961 participants aged ≥ 45 years in 2006, who did not have dementia or glaucoma between 2002 and 2005, were included. METHODS: Data were collected from a nationwide population-based retrospective cohort study using the Korean NHIS database...
February 21, 2023: Ophthalmology
Inas F Aboobakar, Tyler G Kinzy, Yan Zhao, Baojian Fan, Louis R Pasquale, Ayub Qassim, Antonia Kolovos, Joshua M Schmidt, Jamie E Craig, Jessica N Cooke Bailey, Janey L Wiggs
PURPOSE: Genetic variants in regions that include the mitochondrial genes TXNRD2 and ME3 are associated with primary open-angle glaucoma (POAG) in genome-wide association studies (GWAS). To assess their clinical impact, we investigated whether TXNRD2 and ME3 genetic risk scores (GRSs) are associated with specific glaucoma phenotypes. DESIGN: Cross-sectional study PARTICIPANTS: 2617 POAG cases and 2634 controls from the NEIGHBORHOOD consortium. METHODS: All POAG-associated single nucleotide polymorphisms (SNPs) in the TXNRD2 and ME3 loci were identified using GWAS data (p<0...
February 20, 2023: Ophthalmology
Jason Betz, Hannah Behrens, Brooke M Harkness, Richard Stutzman, Winston Chamberlain, Marie Perez Blanco, Deborah M Hegarty, Sue A Aicher, Anat Galor
PURPOSE: To examine the frequency and risk factors for ocular pain after laser assisted in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK). METHODS: Prospective study of individuals undergoing refractive surgery at two different centers. Participants rated their ocular pain on a 0 - 10 Numerical Rating Scale (NRS) pre-surgery and 1 day, 3 months, and 6 months post-surgery. A clinical examination focused on ocular surface health was performed 3- and 6-months post-surgery...
February 19, 2023: Ophthalmology
M Pazos, J Riera, A Moll-Udina, A Catala, S Narvaez, I Fuertes, M Dotti-Boada, G Petiti, J Izquierdo-Serra, E Maldonado, M Chang-Sotomayor, D Garcia, A Camós-Carreras, V Gilera, N De Loredo, J Peraza, N Ventura, F Spencer, G F Del Carlo, J Torras, J M Nicolas, A Adán, A Vilella, S Puig, E Martinez, M J Martinez, B Sánchez-Dalmau, J L Blanco
Ocular complications of mpox infection have a prevalence of 1% in the current outbreak. Although conjunctivitis is the most common presentation, corneal involvement may occur. Tecovirimat is recommended for severe ocular mpox involvement.
February 16, 2023: Ophthalmology
Aafreen Bari, Ritweez Sahu, Rajesh Sinha
No abstract text is available yet for this article.
February 14, 2023: Ophthalmology
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.